Public Health - Medetomidine and Xylazine Consumer Protection Act

File SB435 ("Public Health - Medetomidine and Xylazine Consumer Protection Act") is before the Maryland Legislature and has not been decided. Latest step (April 13, 2026): Motion Laid Over (Senator Ready) Adopted.

Maryland file SB435, before the Maryland Legislature. No action in 221 days as of 2026-04-13.

Official summary

Official synopsis: Prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine product or xylazine product unless the purchaser provides proof the intended use is for institutional, veterinary, or scientific purposes; prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine or xylazine product to an individual under the age of 21 years; requiring a retailer that prepares, distributes, sells, or exposes for sale a medetomidine or xylazine product to maintain certain records; etc.

Read the official record for SB435

See everything up for a vote · This week in Maryland · See what we have filed with the clerk